批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2019/02/25 |
SUPPL-36(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/05/20 |
SUPPL-31(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/01/08 |
SUPPL-30(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/03/23 |
SUPPL-29(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/01/09 |
SUPPL-28(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2012/12/10 |
SUPPL-27(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2012/03/07 |
SUPPL-26(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2010/12/10 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2010/12/08 |
SUPPL-22(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/08/17 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/09/16 |
SUPPL-13(补充) |
Approval |
Efficacy |
UNKNOWN
|
|
|
2006/02/03 |
SUPPL-3(补充) |
Approval |
Efficacy |
UNKNOWN
|
|
|
2005/11/21 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/11/21 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/05/02 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2004/10/29 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:ALBUTEROL SULFATE 剂型/给药途径:AEROSOL, METERED;INHALATION 规格:EQ 0.09MG BASE/INH 治疗等效代码:AB2
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021457 |
001 |
NDA |
PROAIR HFA |
ALBUTEROL SULFATE |
AEROSOL, METERED;INHALATION |
EQ 0.09MG BASE/INH |
Prescription |
Yes |
Yes |
AB2 |
2004/10/29
|
TEVA BRANDED PHARM |
209954 |
001 |
ANDA |
ALBUTEROL SULFATE |
ALBUTEROL SULFATE |
AEROSOL, METERED;INHALATION |
EQ 0.09MG BASE/INH |
Prescription |
No |
No |
AB2 |
2020/08/24
|
LUPIN |
212447 |
001 |
ANDA |
ALBUTEROL SULFATE |
ALBUTEROL SULFATE |
AEROSOL, METERED;INHALATION |
EQ 0.09MG BASE/INH |
Prescription |
No |
No |
AB2 |
2024/05/21
|
ARMSTRONG PHARMS |